Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Bambusa Therapeutics operates as biotechnology company.
MaaT Pharma (Microbiota as a Therapy) is a French biotech start-up.
Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.
VeraDermics is a dermatology company that creates novel drug delivery mechanisms for a pain-free cure for skin conditions.
BRIUS is a healthcare company that focuses in the orthodontics and medical device industry.
ClearScore is a fintech company that provides free credit scores, credit reports, and financial product recommendations to consumers.
Dorsia is a members-only platform that offers reservations at in-demand restaurants in major cities
Horama develops gene therapies for rare inherited ocular and CNS (central nervous system) diseases.
Tasca is a biotechnology company that offers small molecule drugs for hard-to-treat oncology indications.
City Therapeutics is a biopharmaceutical company focused on developing next-generation small interfering RNAs.
Convergent Therapeutics is a pharmaceutical company that focuses on developing radiopharmaceutical therapies for prostate cancer.
Amount is a digital technology company that accelerates digital transformation for financial institutions.
Neptune Medical is a medical device company that develops endoscopic and surgical devices.
Pioneering Potent, Safer Cell Therapy in and Beyond Oncology
Exsilio develops genomic therapeutics that introduce therapeutic genes into safe shelters within the DNA.
Pi Health is a provider of platforms to assist oncology-related clinical trials with identifying sites and helping sponsors manage sites
Mission Lane is a consumer finance company dedicated to helping everyone have access to fair and clear credit.
NextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients.
Adevinta is a digital marketplace that provides online classifieds services.
Lyndra Therepeutics creates therapies for long-term drug release in an oral dose form.
HDAI is an health care analytics company with a platform that creates a shared understanding of health risks and personalized care profiles.
Finastra provides the broadest portfolio of financial services software.
Tisento Therapeutics is a MA-based developer of novel medicines to treat diseases with significant unmet medical needs.
Septerna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.
Invus has invested in 117 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Invus's top investment sectors include Health Care, Biotechnology, Medical, Life Science, Pharmaceutical. The firm invests across 31 different industry categories.
Among tracked funding rounds, Finastra received $5.3B in a Debt Financing round. Invus's total known invested capital is $9.5B.
Invus's average investment size is $93.6M across its portfolio of 117 companies.
Recent Invus portfolio additions include Bambusa Therapeutics, MaaT Pharma, Hemab, VeraDermics, BRIUS. These companies were founded in 2020 or later.